Nina DiPrimio, Ph.D., joined StrideBio as Director of Strategic Alliances in 2019. Dr. DiPrimio was previously the Director of Research and Development at Perlara, where she managed multiple small molecule drug discovery programs for rare genetic diseases such as congenital disorders of glycosylation and Lysosomal storage disorders. She also oversaw academic, industry and foundation partnerships. Before her role at Perlara, she completed her postdoctoral work in Synthetic Biology at University of California, Berkeley and taught laboratory courses at Carnegie Mellon University. Dr. DiPrimio earned her Ph.D. in Pharmacology, with a specific focus on adeno-associated virus capsid biology and vector design, from the University of North Carolina at Chapel Hill.
Nina DiPrimio, Ph.D.
DIRECTOR, STRATEGIC ALLIANCES